QQQ   341.10 (-1.01%)
AAPL   159.22 (-0.29%)
MSFT   299.84 (+1.05%)
FB   294.64 (+0.00%)
GOOGL   2,580.10 (-0.18%)
AMZN   2,792.75 (+0.55%)
TSLA   829.10 (-11.55%)
NVDA   219.44 (-3.64%)
BABA   111.79 (-1.39%)
NIO   21.11 (-6.84%)
AMD   102.60 (-7.33%)
CGC   6.85 (-5.26%)
MU   78.72 (-3.96%)
GE   89.90 (+0.65%)
T   24.12 (-0.54%)
F   19.55 (-1.81%)
DIS   135.42 (+1.36%)
AMC   14.52 (-8.91%)
PFE   53.37 (+0.68%)
ACB   3.79 (-6.65%)
BA   189.75 (-2.33%)
QQQ   341.10 (-1.01%)
AAPL   159.22 (-0.29%)
MSFT   299.84 (+1.05%)
FB   294.64 (+0.00%)
GOOGL   2,580.10 (-0.18%)
AMZN   2,792.75 (+0.55%)
TSLA   829.10 (-11.55%)
NVDA   219.44 (-3.64%)
BABA   111.79 (-1.39%)
NIO   21.11 (-6.84%)
AMD   102.60 (-7.33%)
CGC   6.85 (-5.26%)
MU   78.72 (-3.96%)
GE   89.90 (+0.65%)
T   24.12 (-0.54%)
F   19.55 (-1.81%)
DIS   135.42 (+1.36%)
AMC   14.52 (-8.91%)
PFE   53.37 (+0.68%)
ACB   3.79 (-6.65%)
BA   189.75 (-2.33%)
QQQ   341.10 (-1.01%)
AAPL   159.22 (-0.29%)
MSFT   299.84 (+1.05%)
FB   294.64 (+0.00%)
GOOGL   2,580.10 (-0.18%)
AMZN   2,792.75 (+0.55%)
TSLA   829.10 (-11.55%)
NVDA   219.44 (-3.64%)
BABA   111.79 (-1.39%)
NIO   21.11 (-6.84%)
AMD   102.60 (-7.33%)
CGC   6.85 (-5.26%)
MU   78.72 (-3.96%)
GE   89.90 (+0.65%)
T   24.12 (-0.54%)
F   19.55 (-1.81%)
DIS   135.42 (+1.36%)
AMC   14.52 (-8.91%)
PFE   53.37 (+0.68%)
ACB   3.79 (-6.65%)
BA   189.75 (-2.33%)
QQQ   341.10 (-1.01%)
AAPL   159.22 (-0.29%)
MSFT   299.84 (+1.05%)
FB   294.64 (+0.00%)
GOOGL   2,580.10 (-0.18%)
AMZN   2,792.75 (+0.55%)
TSLA   829.10 (-11.55%)
NVDA   219.44 (-3.64%)
BABA   111.79 (-1.39%)
NIO   21.11 (-6.84%)
AMD   102.60 (-7.33%)
CGC   6.85 (-5.26%)
MU   78.72 (-3.96%)
GE   89.90 (+0.65%)
T   24.12 (-0.54%)
F   19.55 (-1.81%)
DIS   135.42 (+1.36%)
AMC   14.52 (-8.91%)
PFE   53.37 (+0.68%)
ACB   3.79 (-6.65%)
BA   189.75 (-2.33%)
NASDAQ:ELOX

Eloxx Pharmaceuticals Insider Trades

$0.45
-0.07 (-13.54%)
(As of 01/27/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.44
$0.53
50-Day Range
$0.44
$0.78
52-Week Range
$0.37
$4.98
Volume
270,867 shs
Average Volume
325,320 shs
Market Capitalization
$38.55 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.29

Eloxx Pharmaceuticals (NASDAQ:ELOX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
34.60%

Number Of
Insiders Buying
(Last 12 Months)
3

Amount Of
Insider Buying
(Last 12 Months)
$11.37 M

Number Of
Insiders Selling
(Last 12 Months)
0

Skip Chart & View Insider Trade History

Insider Buying and Selling by Quarter

Get ELOX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Eloxx Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Eloxx Pharmaceuticals (NASDAQ ELOX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/29/2021Daniel E GeffkenCFOBuy50,000$0.72$36,000.00  
5/13/2021Pontifax Management 4 G.P. (20Major ShareholderBuy5,925,925$1.35$7,999,998.75  
5/13/2021Rajesh B ParekhDirectorBuy2,466,666$1.35$3,329,999.10  
6/24/2019Pontifax Management 4 G.P. (20Major ShareholderBuy200,000$9.00$1,800,000.00  
5/22/2018Robert WardCEOBuy5,000$14.34$71,700.00  
4/30/2018Gilad ShabtaiMajor ShareholderBuy75,000$9.75$731,250.00  
4/30/2018Tomer KarivDirectorBuy350,000$9.75$3,412,500.00  
4/4/2018Gilad ShabtaiMajor ShareholderBuy8,300$9.46$78,518.00  
3/29/2018Gilad ShabtaiMajor ShareholderBuy4,500$9.64$43,380.00  
3/26/2018Zafrira AvnurDirectorBuy2,000$9.49$18,980.00  
3/23/2018Gregory L WeaverCFOBuy4,500$8.56$38,520.00  
3/23/2018Robert WardCEOBuy10,000$8.99$89,900.00  
3/22/2018Pontifax Management 4 G.P. (20Major ShareholderBuy12,600$7.76$97,776.00  
3/21/2018Zafrira AvnurDirectorBuy263$7.60$1,998.80  
(Data available from 1/1/2013 forward)












Eloxx Pharmaceuticals (NASDAQ:ELOX) Insider Trade Frequently Asked Questions

Who is on Eloxx Pharmaceuticals's Insider Roster?

The list of insiders at Eloxx Pharmaceuticals includes Daniel E Geffken, Pontifax Management 4 G.P. (20, and Rajesh B Parekh.Learn more on ELOX's insiders

What percentage of Eloxx Pharmaceuticals stock is owned by insiders?

34.60% of Eloxx Pharmaceuticals stock is owned by insiders. Learn more on ELOX's insider holdings

Which Eloxx Pharmaceuticals insiders have been buying company stock?

The following insiders have purchased Eloxx Pharmaceuticals stock in the last 24 months: Daniel E Geffken ($36,000.00), Pontifax Management 4 G.P. (20 ($7,999,998.75), and Rajesh B Parekh ($3,329,999.10).

How much insider buying is happening at Eloxx Pharmaceuticals?

Insiders have purchased a total of 8,442,591 Eloxx Pharmaceuticals shares in the last 24 months for a total of $11,365,997.85 bought.

This page was last updated on 1/27/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.